Literature DB >> 21707331

Heterosexual anal intercourse: increasing prevalence, and association with sexual dysfunction, bisexual behavior, and venereal disease history.

Stuart Brody1, Petr Weiss.   

Abstract

Representative samples of the Czech population were surveyed with regard to sexual behavior in 1993, 1998, 2003, and 2008 (N = 7,720). Lifetime prevalence of Heterosexual Anal Intercourse increased from 1993 to 2008 (16.6% to 19.7% among women, 15.7% to 25.3% among men). Anal intercourse was associated with lifetime number of sex partners, current masturbation, and histories (prevalence of which increased from 1993 to 2008) of homosexual sex, prostitution, venereal disease (adjusted for number of sex partners), and women's sexual dysfunction. The authors discuss the possible reasons for the increasing prevalence and the associations. Multivariate predictors of ever having a sexual dysfunction or a venereal disease are also presented.

Entities:  

Mesh:

Year:  2011        PMID: 21707331     DOI: 10.1080/0092623X.2011.582436

Source DB:  PubMed          Journal:  J Sex Marital Ther        ISSN: 0092-623X


  8 in total

1.  An Electronic Daily Diary Study of Anal Intercourse in Drug-Using Women.

Authors:  Grace L Reynolds; Dennis G Fisher; Jean-Philippe Laurenceau; J Dennis Fortenberry
Journal:  AIDS Behav       Date:  2015-12

2.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female anorectal dysfunction.

Authors:  Abdul H Sultan; Ash Monga; Joseph Lee; Anton Emmanuel; Christine Norton; Giulio Santoro; Tracy Hull; Bary Berghmans; Stuart Brody; Bernard T Haylen
Journal:  Int Urogynecol J       Date:  2016-10-24       Impact factor: 2.894

3.  Increased Body Mass Index Associated with Increased Risky Sexual Behaviors.

Authors:  Lonna P Gordon; Angela Diaz; Christine Soghomonian; Anne T Nucci-Sack; Jocelyn M Weiss; Howard D Strickler; Robert D Burk; Nicolas F Schlecht; Christopher N Ochner
Journal:  J Pediatr Adolesc Gynecol       Date:  2015-06-06       Impact factor: 1.814

4.  Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques.

Authors:  Lara E Pereira; Tyana Singletary; Amy Martin; Chuong T Dinh; Frank Deyounks; Angela Holder; Janet McNicholl; Karen W Buckheit; Robert W Buckheit; Anthony Ham; David F Katz; James M Smith
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

5.  Pharmacokinetic and Pharmacodynamic Evaluation following Vaginal Application of IQB3002, a Dual-Chamber Microbicide Gel Containing the Nonnucleoside Reverse Transcriptase Inhibitor IQP-0528 in Rhesus Macaques.

Authors:  Lara E Pereira; Pedro M M Mesquita; Anthony Ham; Tyana Singletary; Frank Deyounks; Amy Martin; Janet McNicholl; Karen W Buckheit; Robert W Buckheit; James M Smith
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

6.  Heterosexual Practices Among Young People in Britain: Evidence From Three National Surveys of Sexual Attitudes and Lifestyles.

Authors:  Ruth Lewis; Clare Tanton; Catherine H Mercer; Kirstin R Mitchell; Melissa Palmer; Wendy Macdowall; Kaye Wellings
Journal:  J Adolesc Health       Date:  2017-12       Impact factor: 5.012

7.  Compulsive Internet Pornography Use and Mental Health: A Cross-Sectional Study in a Sample of University Students in the United States.

Authors:  Christina Camilleri; Justin T Perry; Stephen Sammut
Journal:  Front Psychol       Date:  2021-01-12

8.  Patterns and Trajectories of Anal Intercourse Practice Over the Life Course Among US Women at Risk of HIV.

Authors:  Branwen Nia Owen; Rebecca F Baggaley; Mathieu Maheu-Giroux; Jocelyn Elmes; Adaora A Adimora; Catalina Ramirez; Andrew Edmonds; Kemi Sosanya; Tonya Taylor; Michael Plankey; Julie Cederbaum; Dominika Seidman; Kathleen M Weber; Elizabeth T Golub; Anandi N Sheth; Hector Bolivar; Deborah Konkle-Parker; Marie-Claude Boily
Journal:  J Sex Med       Date:  2020-07-20       Impact factor: 3.937

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.